Rate this Article: A Prospective Comparison of the Ondansetron Plus Aprepitant, Versus Ondansetron for the Prevention of Chemotherapy Induced Nausea and Vomiting

Rating (1-10):

1

Comments (SUB153587):

Please enter 100–200 characters. 0/200 characters

Full Name: Email Address (Important: You will receive Rating Verification Link on this Email Address):

Leave this field empty

Back to Article